Latest Insider Transactions at Allakos Inc. (ALLK)
This section provides a real-time view of insider transactions for Allakos Inc. (ALLK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Allakos Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Allakos Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 02
2022
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,084
-1.03%
|
$16,168
$2.75 P/Share
|
Jun 02
2022
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,219
-0.92%
|
$10,438
$2.75 P/Share
|
Jun 02
2022
|
Margaret Nell Fitzgerald General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-0.21%
|
$636
$2.75 P/Share
|
Jun 02
2022
|
Harlan Baird Radford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,274
-0.82%
|
$4,548
$2.75 P/Share
|
Jun 02
2022
|
Craig A. Paterson Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
226
-0.08%
|
$452
$2.75 P/Share
|
Apr 19
2022
|
Margaret Nell Fitzgerald General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
57,637
+27.65%
|
-
|
Mar 02
2022
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,215
-1.03%
|
$41,075
$5.38 P/Share
|
Mar 02
2022
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,582
-0.97%
|
$27,910
$5.38 P/Share
|
Mar 02
2022
|
Mark Asbury CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,680
-0.73%
|
$8,400
$5.38 P/Share
|
Feb 25
2022
|
Adam Tomasi President |
BUY
Grant, award, or other acquisition
|
Direct |
344,060
+37.45%
|
-
|
Feb 25
2022
|
Harlan Baird Radford Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
237,608
+46.0%
|
-
|
Feb 25
2022
|
Mark Asbury CLO |
BUY
Grant, award, or other acquisition
|
Direct |
140,490
+38.06%
|
-
|
Feb 25
2022
|
Robert Alexander Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
529,323
+39.97%
|
-
|
Dec 02
2021
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,241
-7.09%
|
$1,578,798
$78.69 P/Share
|
Dec 02
2021
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
13,067
-5.37%
|
$1,019,226
$78.69 P/Share
|
Dec 01
2021
|
Robert Alexander Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,681
+15.33%
|
-
|
Dec 01
2021
|
Adam Tomasi President |
BUY
Grant, award, or other acquisition
|
Direct |
33,362
+12.06%
|
-
|
Dec 01
2021
|
Harlan Baird Radford Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,255
+36.97%
|
-
|
Dec 01
2021
|
Mark Asbury CLO |
BUY
Grant, award, or other acquisition
|
Direct |
26,003
+22.85%
|
-
|
Sep 28
2021
|
Steven P James |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$432,000
$108.12 P/Share
|
Sep 28
2021
|
Steven P James |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$0
$0.52 P/Share
|
Sep 02
2021
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,346
-1.1%
|
$213,486
$91.66 P/Share
|
Sep 02
2021
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,985
-1.68%
|
$362,635
$91.66 P/Share
|
Sep 02
2021
|
Mark Asbury CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
698
-1.12%
|
$63,518
$91.66 P/Share
|
Aug 31
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
64,148
+23.2%
|
$256,592
$4.31 P/Share
|
Jun 15
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.63%
|
$0
$0.69 P/Share
|
Jun 15
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.89%
|
$1,820,000
$91.03 P/Share
|
Jun 14
2021
|
Adam Tomasi President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.63%
|
$0
$0.69 P/Share
|
Jun 14
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
20,000
-11.89%
|
$1,820,000
$91.62 P/Share
|
Jun 07
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
2,487
-1.65%
|
$228,804
$92.03 P/Share
|
Jun 04
2021
|
Adam Tomasi President |
SELL
Open market or private sale
|
Direct |
642
-0.42%
|
$57,780
$90.26 P/Share
|
Jun 04
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,435
-2.41%
|
$216,715
$89.6 P/Share
|
Jun 04
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
5,482
-1.68%
|
$487,898
$89.64 P/Share
|
Jun 04
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,113
-3.62%
|
$1,612,057
$89.63 P/Share
|
Jun 04
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,516
+5.44%
|
$0
$0.69 P/Share
|
Jun 03
2021
|
Adam Tomasi President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,777
-1.16%
|
$163,484
$92.2 P/Share
|
Jun 03
2021
|
Mark Asbury CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
734
-1.16%
|
$67,528
$92.2 P/Share
|
Jun 03
2021
|
Henrik S Md Rasmussen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-0.82%
|
$76,728
$92.2 P/Share
|
Jun 03
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
5,484
-1.66%
|
$504,528
$92.09 P/Share
|
Jun 03
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,517
+5.29%
|
$0
$0.69 P/Share
|
Jun 03
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,517
-5.59%
|
$1,335,564
$92.14 P/Share
|
Jun 03
2021
|
Robert Alexander Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,003
-1.63%
|
$368,276
$92.2 P/Share
|
Jun 02
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
5,484
-1.63%
|
$515,496
$94.56 P/Share
|
Jun 02
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,517
+5.29%
|
$0
$0.69 P/Share
|
Jun 02
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,517
-5.59%
|
$1,364,598
$94.55 P/Share
|
May 19
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,516
+5.29%
|
$0
$0.69 P/Share
|
May 19
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,516
-5.59%
|
$1,422,568
$98.94 P/Share
|
May 18
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,517
+5.29%
|
$0
$0.69 P/Share
|
May 18
2021
|
Robert Alexander Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,517
-5.59%
|
$1,480,734
$102.32 P/Share
|
May 17
2021
|
Robert Alexander Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,517
+5.29%
|
$0
$0.69 P/Share
|